valganciclovir
Term · Oncology and biomedicine · MLC-T-ONC-009153
An antiviral agent that is being studied as a treatment for AIDS-related cytomegalovirus. It is changed in the body to ganciclovir.
A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication.
| Identifier | MLC-T-ONC-009153 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | VGCV |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009153",
"term": "valganciclovir",
"field": "Oncology and biomedicine",
"definitions": [
"An antiviral agent that is being studied as a treatment for AIDS-related cytomegalovirus. It is changed in the body to ganciclovir.",
"A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication."
],
"abbreviation": "VGCV",
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/valganciclovir/"
}
Record 17,094 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.